Related Experiment Video
Updated: Jul 29, 2025

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Recurrent thromboembolism due to direct oral anticoagulation interruption postpericardial window for a
Onoriode Kesiena1, Shreyas Singireddy1, Syed Hyder2
1Department of Internal Medicine, Piedmont Athens Regional Medical Center, Athens, GA 30606, USA.
Abstract:
We present a female patient with a history of systolic heart failure with an ejection fraction of 25-30%, and unprovoked pulmonary embolism on extended anticoagulation therapy with rivaroxaban who underwent a pericardial window for cardiac tamponade due to hemopericardium in the setting of direct oral anticoagulant (DOAC). The rivaroxaban was held following the pericardial window, and she experienced another episode of pulmonary embolism before the rivaroxaban could be restarted. Currently, there are no guidelines on when to restart anticoagulation postpericardial window for DOAC-associated hemopericardium. Studies are needed to help solve this dilemma.
More Related Videos
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pericarditis III: Medical Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiac Catheterization II: Right Heart Catheterization
Pulmonary Embolism I: Introduction